Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Acute Neurological Injury, Acute Medical Conditions

In brief

This study will demonstrate the impact of taVNS on reducing adverse events in NeuroICU patients, determine if taVNS reduces length of stay, and quantify the economic benefits of taVNS implementation in a broader neurocritical care population.

Key facts

Study ID
NCT07219108
Run by
Washington University School of Medicine
People needed
160
Starts
2025-09-24
Expected to finish
2027-09-23
Last updated by the study team
2025-10-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.